CTO co-hosts session on rare disease and genomics at BIO 2019
More than 170 representatives from academia, the Ontario and Québec governments, multi-national pharmaceutical companies, biotech companies, and contract research organizations attended the session, titled “Rare Disease and Genomics in 3D: From Diagnostics to Data to Drug Discovery and Development.”